The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1806 November 28, 2002 Number 22
NextNext

Specific Removal of ß1-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: The pathophysiologic relevance of autoantibodies against cardiac proteins in the induction or maintenance of idiopathic dilated cardiomyopathy is still unclear. It has been shown that induction of antibodies against cardiac {beta}1-adrenergic–receptor structures in rabbits leads to significant cardiac dilatation.1,2 Examinations of cardiac myocytes from neonatal rats have shown that this antibody type isolated from patients with idiopathic dilated cardiomyopathy acts like a {beta}-adrenergic agonist.3 Removal of class G immunoglobulins from plasma has been shown to improve cardiac performance within one year after immunoadsorption in patients with idiopathic dilated cardiomyopathy.4 Since immunoadsorption removes a whole class of immunoglobulins, . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.